SP 500 Hits Fresh High as Tech Surge Offsets Energy Slide Fanatics Secures FIFA Exclusive License Bolstering Dominance in Sports Collectibles Market Bureau of Prisons Adopts AI Technology Signaling Shift in Federal Facility Management AI Industry Emerges as Key Beneficiary of HighProfile MuskAltman Legal Proceedings Meta Launches Subscription Plans for Instagram Facebook and Debuts AI Paid Tier NXPI Q1 2026 Earnings EPS Surpasses Estimates Stock Rallies 57 BBW Q1 2026 Earnings EPS Beats Estimates by 226 Amid Mixed Market Sentiment JJSF Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Operating Environment 5E Advanced Materials Inc FEAM Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Phase Continues iRadimed IRMD Q1 2026 Earnings Strong EPS Beat Lifts Shares Despite Limited Revenue Disclosure Tripcom Group TCOM Rallies 21 to 4735 as Travel Demand Signals Strengthen AeroVironment AVAV Surges 68 Defense Momentum and Key Levels to Watch ARQQW Warrants Tumble 10 Testing Key Support at 007 rYojbaba Co Ltd RYOJ Faces Sharp 15 Drop as Support Levels Are Tested PCB Bancorp PCB Slides 177 as Regional Bank Sentiment Weakens Citius Oncology CTOR Edges Lower as Stock Holds Above Key Support Memory Chip Giants SK Hynix and Micron Surpass 1 Trillion Valuation Amid AIDriven Market Surge KELYA Q1 2026 Earnings EPS Misses Estimates as Staffing Challenges Persist Investor Home Purchases Plunge to Lowest Levels Since Pandemic Shutdown Greenfire Resources GFR Slides 299 as Shares Test Key Support Zone XMAX Inc XWIN Holds Steady at 824 as Market Awaits Catalyst Sweetgreen Inc SG Surges 78 as Buyers Step In Near Key Support Hyliion Holdings HYLN Surges 42 Key Levels and Market Reaction Weyco Group WEYS Gains 357 as Stock Approaches Key Resistance Level Teekay Tankers TNK Slides 3 as Crude Tanker Rates Weigh on Shipping Sector MREO Edges Higher Holding Near Support as Biotech Sector Watches Nvidia Earnings Spotlight Jensen Huangs Commentary on China and Trump Relations Could Move Markets DNA Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Amid Ongoing Restructuring Nurix Therapeutics NRIX Rallies 230 as Buyers Test Resistance Near 1867